Dr. Mark A LaBarge is a Professor and Stem Cell Biologist in the Department of Population
Sciences at the Beckman Research Institute at City of Hope National Medical
Center. He received his B.S. in Genetics from the University of California,
Davis in 1996 and his Ph.D. in Molecular Pharmacology from Stanford University
in 2004. He completed his postdoctoral training at the Lawrence Berkeley
National Laboratory, where he served as an American Cancer Society Fellow, and
built novel high throughput cell-based systems for studying human mammary stem
cell fate decisions in the contexts of combinatorial microenvironments. His
research focuses on the areas of Aging and Breast Cancer,
Microenvironment, Early Events in Cancer, and Biomarkers of Early Detection and
Prevention. In 2009 he won a Transition to Independence Award from the National
Institute on Aging and joined the LBNL faculty. In 2015 he was awarded the Era
of Hope Scholar Award from the Congressionally Directed Medical Research
Program to support his team’s efforts to translate their laboratory findings
into prevention-focused breast cancer therapeutics, which is a major focus of
his current research.
Dr. Mark A LaBarge is a Professor and Stem Cell Biologist in the Department of Population
Sciences at the Beckman Research Institute at City of Hope National Medical
Center. He received his B.S. in Genetics from the University of California,
Davis in 1996 and his Ph.D. in Molecular Pharmacology from Stanford University
in 2004. He completed his postdoctoral training at the Lawrence Berkeley
National Laboratory, where he served as an American Cancer Society Fellow, and
built novel high throughput cell-based systems for studying human mammary stem
cell fate decisions in the contexts of combinatorial microenvironments. His
research focuses on the areas of Aging and Breast Cancer,
Microenvironment, Early Events in Cancer, and Biomarkers of Early Detection and
Prevention. In 2009 he won a Transition to Independence Award from the National
Institute on Aging and joined the LBNL faculty. In 2015 he was awarded the Era
of Hope Scholar Award from the Congressionally Directed Medical Research
Program to support his team’s efforts to translate their laboratory findings
into prevention-focused breast cancer therapeutics, which is a major focus of
his current research.